Liposomal encapsulated anti-cancer drugs
Ralf‐Dieter Hofheinz(University of Mannheim), Andreas Hochhaus(Jena University Hospital), Senta Ulrike Gnad-Vogt(University Medical Centre Mannheim), Ulrich Beyer(Roche (Switzerland))
Cited by 357
Related Papers
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
|Leukemia|2022|3.8k
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
|New England Journal of Medicine|2015|1.7k
Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial
|Leukemia|2016|849